REFERENCES
1. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8:30.
2. Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14:301-16.
3. Yin J, Xie L, Luo D, et al. Changes of structural and functional attention control networks in subclinical hypothyroidism. Front Behav Neurosci. 2021;15:725908.
4. Samuels MH, Bernstein LJ. Brain fog in hypothyroidism: what is it, how is it measured, and what can be done about it. Thyroid. 2022;32:752-63.
5. Yin JJ, Liao LM, Luo DX, et al. Spatial working memory impairment in subclinical hypothyroidism: an FMRI study. Neuroendocrinology. 2013;97:260-70.
6. Zhang T, Zhao L, Chen C, et al. Structural and functional alterations of hippocampal subfields in patients with adult-onset primary hypothyroidism. J Clin Endocrinol Metab. 2024;109:1707-17.
7. Beydoun MA, Beydoun HA, Rostant OS, et al. Thyroid hormones are associated with longitudinal cognitive change in an urban adult population. Neurobiol Aging. 2015;36:3056-66.
8. Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:4240-8.
9. Borkowski K, Taha AY, Pedersen TL, et al. Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. Sci Rep. 2021;11:18964.
10. Gómez-Pascual A, Naccache T, Xu J, et al. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer’s disease. Comput Biol Med. 2024;176:108588.
11. Wang S, Xu C, Liu H, et al. Connecting the gut microbiota and neurodegenerative diseases: the role of bile acids. Mol Neurobiol. 2023;60:4618-40.
12. Xing C, Huang X, Wang D, et al. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023;13:106.
14. Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11:158-71.
15. Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236-47.
16. McMillin M, DeMorrow S. Effects of bile acids on neurological function and disease. FASEB J. 2016;30:3658-68.
17. MahmoudianDehkordi S, Arnold M, Nho K, et al.; Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium. Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease-An emerging role for gut microbiome. Alzheimers Dement. 2019;15:76-92.
18. Nho K, Kueider-Paisley A, MahmoudianDehkordi S, et al.; Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium. Altered bile acid profile in mild cognitive impairment and Alzheimer’s disease: relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 2019;15:232-44.
19. Nie K, Li Y, Zhang J, et al. Distinct bile acid signature in Parkinson’s disease with mild cognitive impairment. Front Neurol. 2022;13:897867.
20. Ren Z, Zhao L, Zhao M, et al. Increased intestinal bile acid absorption contributes to age-related cognitive impairment. Cell Rep Med. 2024;5:101543.
21. Marksteiner J, Blasko I, Kemmler G, Koal T, Humpel C. Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease. Metabolomics. 2018;14:1.
22. Olazarán J, Gil-de-Gómez L, Rodríguez-Martín A, et al. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer’s disease. J Alzheimers Dis. 2015;45:1157-73.
23. Chen SJ, Chen CC, Liao HY, et al. Alteration of gut microbial metabolites in the systemic circulation of patients with Parkinson’s disease. J Parkinsons Dis. 2022;12:1219-30.
24. Li J, Xu Y, Cai Y, et al. Association of differential metabolites with small intestinal microflora and maternal outcomes in subclinical hypothyroidism during pregnancy. Front Cell Infect Microbiol. 2021;11:779659.
25. Shao F, Li R, Guo Q, et al. Plasma metabolomics reveals systemic metabolic alterations of subclinical and clinical hypothyroidism. J Clin Endocrinol Metab. 2022;108:13-25.
26. Song Y, Zhao M, Zhang H, et al. Thyroid-stimulating hormone levels are inversely associated with serum total bile acid levels: a cross-sectional study. Endocr Pract. 2016;22:420-6.
27. Endocrinology CSo. Guidelines for diagnosis and management of hypothyroidism in adults. Chin J Endocrinol Metab. 2017;33:167-80.
28. Yu J, Li J, Huang X. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry. 2012;12:156.
29. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9.
30. Hang S, Paik D, Yao L, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-8.
31. Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30:289-300.
32. Shao Y, Ouyang Y, Li T, et al. Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer’s disease. Aging Dis. 2020;11:1459-70.
33. MahmoudianDehkordi S, Bhattacharyya S, Brydges CR, et al. Gut microbiome-linked metabolites in the pathobiology of major depression with or without anxiety-a role for bile acids. Front Neurosci. 2022;16:937906.
34. Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019;39:175-200.
35. Yang R, Qian L. Research on gut microbiota-derived secondary bile acids in cancer progression. Integr Cancer Ther. 2022;21:15347354221114100.
36. Lee JW, Cowley ES, Wolf PG, et al. Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes. Gut Microbes. 2022;14:2132903.
37. Ridlon JM, Gaskins HR. Another renaissance for bile acid gastrointestinal microbiology. Nat Rev Gastroenterol Hepatol. 2024;21:348-64.
38. Kiriyama Y, Nochi H. The biosynthesis, signaling, and neurological functions of bile acids. Biomolecules. 2019;9:232.
39. Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol Sci. 2000;57:177-85.
40. Xu Z, Huang G, Gong W, et al. FXR ligands protect against hepatocellular inflammation via SOCS3 induction. Cell Signal. 2012;24:1658-64.
41. Low DY, Lefèvre-Arbogast S, González-Domínguez R, et al. Diet-related metabolites associated with cognitive decline revealed by untargeted metabolomics in a prospective cohort. Mol Nutr Food Res. 2019;63:e1900177.
42. Lamireau T, Zoltowska M, Levy E, et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci. 2003;72:1401-11.
43. Xie G, Wang X, Jiang R, et al. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure. EBioMedicine. 2018;37:294-306.
44. Baloni P, Funk CC, Yan J, et al.; Alzheimer’s Disease Metabolomics Consortium. Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer’s disease. Cell Rep Med 2020;1:100138. Available from: https://scholar.google.com/scholar?q=Metabolic+network+analysis+reveals+altered+bile+acid+synthesis+and+metabolism+in+Alzheimer%E2%80%99s+disease&hl=zh-CN&as_sdt=0&as_vis=1&oi=scholart. [Last accessed on 30 Mar 2026].
45. Oizumi K, Sekine S, Fukagai M, Susukida T, Ito K. Identification of bile acids responsible for inhibiting the bile salt export pump, leading to bile acid accumulation and cell toxicity in rat hepatocytes. J Pharm Sci. 2017;106:2412-9.
46. Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851-61.
47. Krell-Roesch J, Syrjanen JA, Vassilaki M, et al. Brain regional glucose metabolism, neuropsychiatric symptoms, and the risk of incident mild cognitive impairment: the Mayo clinic study of aging. Am J Geriatr Psychiatry. 2021;29:179-91.
48. Qian Y, Yang X, Xu S, et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease. Brain. 2020;143:2474-89.
49. Olasunkanmi OI, Zheng L, Zheng P. Gut-brain axis in health and brain disease. Chin Med J. 2026;139:799-827.
50. Liu S, An Y, Cao B, Sun R, Ke J, Zhao D. The composition of gut microbiota in patients bearing Hashimoto’s thyroiditis with euthyroidism and hypothyroidism. Int J Endocrinol. 2020;2020:5036959.
